46,XX testicular difference of sex development is a congenital variation in sex development in which a person has a 46,XX chromosome complement and develops testicular tissue rather than ovarian tissue. External genital anatomy is often typically male, although some individuals have genital differences apparent at birth. Many cases are identified only after puberty during investigation of small testes, reduced testosterone production, or infertility. The condition demonstrates that chromosome complement, gonadal development, and external anatomy are related but distinct aspects of sex development.
Terminology and classification
The chromosome designation 46,XX indicates 46 chromosomes, including two X chromosomes. “Testicular” describes the type of gonadal tissue that develops; it does not imply that testicular function or external anatomy is identical in every affected person.
The condition belongs to the broader group of differences of sex development (DSD). Medical literature also uses “disorders of sex development,” while individual preferences for terminology vary. “46,XX male syndrome” and “De la Chapelle syndrome” are older names. The historical term “true hermaphroditism” is not an appropriate synonym: it referred to the presence of both ovarian and testicular tissue, now termed ovotesticular DSD.
A chromosome result does not by itself establish a person’s gender identity.
Genetic basis
Early embryonic gonads can develop along testicular or ovarian pathways. This process depends on interacting genes and their regulation, rather than on chromosome number alone.
SRY-positive cases
Approximately 80% of individuals with nonsyndromic 46,XX testicular DSD have the SRY gene, which is normally located on the Y chromosome. SRY helps initiate testicular differentiation by activating a network of genes that includes SOX9.
In most SRY-positive cases, a small segment of Y-chromosome material containing SRY has been transferred to an X chromosome through an unusual exchange during sperm formation. Consequently, the person has two X chromosomes on karyotype analysis but also carries genetic material capable of initiating testis development. Most such cases arise as a new genetic event rather than through a recurring family pattern.
SRY-negative cases
Some affected individuals do not have detectable SRY. In these cases, changes elsewhere in the sex-development network can promote testicular development despite its absence. Established mechanisms include changes affecting the dosage or regulation of SOX9 and, more rarely, alterations involving other developmental genes such as SOX3.
Some relevant changes affect regulatory regions rather than protein-coding sequences. They alter gene expression—when, where, or how strongly a gene is active. Routine chromosome analysis or sequencing focused only on coding regions may therefore not identify the cause. In some individuals, the molecular explanation remains unknown.
Clinical features
The presentation varies with the underlying genetic mechanism and the degree of testicular development.
Many SRY-positive individuals have typically male external genitalia and are not recognized as having a sex-development difference during childhood. Possible later findings include:
- Small testes.
- Absent sperm in the ejaculate, termed azoospermia.
- Reduced testosterone production.
- Breast enlargement, or gynecomastia.
- Reduced facial or body hair in some individuals.
Testosterone production can be sufficient for spontaneous puberty, but testicular function may be impaired or decline over time. Blood testing may show low testosterone together with elevated luteinizing hormone and follicle-stimulating hormone, a pattern called hypergonadotropic hypogonadism.
Genital differences at birth are more frequent in SRY-negative cases. These may include hypospadias, in which the urethral opening is not at the tip of the penis, or other differences in external genital development. Internal reproductive anatomy also varies, although a uterus is usually absent when fetal testicular hormone production has been sufficient.
The absence of most Y-chromosome regions required for sperm production explains why infertility is a central feature. The presence of SRY alone is not sufficient to support normal sperm formation.
Diagnosis and related conditions
Diagnosis combines clinical findings with chromosome and molecular testing. Investigation may include a medical history, physical examination, reproductive hormone measurements, and semen analysis when relevant.
Karyotyping establishes the 46,XX chromosome complement. Targeted testing determines whether SRY is present. Additional genetic tests can identify chromosome gains or losses, structural changes, or variants affecting sex-development genes. Ultrasonography may help characterize internal reproductive anatomy.
Important distinctions include:
- 46,XX ovotesticular DSD: both ovarian and testicular tissue are present.
- 46,XX DSD caused by prenatal androgen exposure: external genitalia may be masculinized, but the gonads are ovaries rather than testes.
- Sex-chromosome mosaicism or chimerism: different cell populations have different chromosome complements.
- Klinefelter syndrome: typically associated with a 47,XXY chromosome complement, although small testes and infertility can resemble the adult presentation of 46,XX testicular DSD.
A blood chromosome result does not necessarily characterize every tissue, which can matter when mosaicism is suspected.
Clinical care and inheritance
Clinical care addresses the individual’s endocrine function, anatomy, reproductive circumstances, and psychosocial needs. Testosterone replacement is used in individuals with established testosterone deficiency. Assessment of bone health can be relevant because prolonged sex-hormone deficiency contributes to osteoporosis. Hormone treatment does not restore the missing genetic machinery required for sperm production.
Anatomical interventions are not required in every case. Their relevance depends on the particular anatomy and functional concerns, rather than on the chromosome result alone.
Genetic counseling explains the identified mechanism and its implications for relatives. Recurrence is generally low for a newly arising SRY translocation, whereas some SRY-negative causes can follow inherited patterns. A single recurrence estimate therefore does not apply to all forms of the condition.
Frequency and evidence limitations
46,XX testicular DSD is rare; a frequently cited estimate is approximately one in 20,000 male births. Precise frequency is uncertain because many individuals are diagnosed only during infertility investigations, and access to genetic testing varies.
Much of the published evidence comes from case reports and relatively small clinical series. The full range of SRY-negative genetic mechanisms and long-term outcomes is less well characterized than the common SRY-positive presentation.